« Back to Record
Citation APA

Wechsler, M. M., Nair, P., Terrier, B., Walz, B., Bourdin, A., Jayne, D. R., Jackson, D. J., Roufosse, F., Sjö, L. B., Fan, Y., Jison, M., McCrae, C., Necander, S., Shavit, A., Walton, C., & Merkel, P. P. (2024). Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. The New England journal of medicine, 390(10), 911-921. doi:10.1056/NEJMoa2311155


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/373721

Wechsler, M. M., Nair, P., Terrier, B., Walz, B., Bourdin, A., Jayne, D. R., Jackson, D. J., Roufosse, F., Sjö, L. B., Fan, Y., Jison, M., McCrae, C., Necander, S., Shavit, A., Walton, C., & Merkel, P. P. (2024). Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. The New England journal of medicine, 390(10), 911-921. doi:10.1056/NEJMoa2311155